Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Cedarhurst, NY
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Williamsville, NY
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Williamsville, NY
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Raleigh, NC
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Fargo, ND
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Canton, OH
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Medford, OR
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Portland, OR
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Salem, OR
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Salem, OR
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Allentown, PA
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Warwick, RI
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Chattanooga, TN
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Dallas, TX
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Seattle, WA
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Kenosha, WI
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Kenosha, WI
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Evansville, IN
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated:  4/23/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia
Status: Enrolling
Updated: 4/23/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Trial of Lithium Carbonate for Treatment of Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated:  4/24/2018
University of Maryland Amish Research Clinic
mi
from
Lancaster, PA
Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Trial of Lithium Carbonate for Treatment of Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated: 4/24/2018
University of Maryland Amish Research Clinic
mi
from
Lancaster, PA
Click here to add this to my saved trials
Pain in America: A Randomized Controlled Trial
Status: Enrolling
Updated:  4/24/2018
UMKC Department of Orthopaedic Surgery
mi
from
Kansas City, MO
Pain in America: A Randomized Controlled Trial
Status: Enrolling
Updated: 4/24/2018
UMKC Department of Orthopaedic Surgery
mi
from
Kansas City, MO
Click here to add this to my saved trials
rTMS in Spasmodic Dysphonia
Repetitive Transcranial Magnetic Stimulation in Spasmodic Dysphonia
Status: Enrolling
Updated:  4/24/2018
Noninvasive Neuromodulation Laboratory
mi
from
Minneapolis, MN
rTMS in Spasmodic Dysphonia
Repetitive Transcranial Magnetic Stimulation in Spasmodic Dysphonia
Status: Enrolling
Updated: 4/24/2018
Noninvasive Neuromodulation Laboratory
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Neurotoxin and Physical Therapy
Synergistic Effects of Neurotoxin and Physical Therapy
Status: Enrolling
Updated:  4/25/2018
University of Florida
mi
from
Gainesville, FL
Neurotoxin and Physical Therapy
Synergistic Effects of Neurotoxin and Physical Therapy
Status: Enrolling
Updated: 4/25/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Movement-Related Brain Networks Involved in Hand Dystonia
The Role of Cortical Coherence in Focal Hand Dystonia
Status: Enrolling
Updated:  4/28/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Movement-Related Brain Networks Involved in Hand Dystonia
The Role of Cortical Coherence in Focal Hand Dystonia
Status: Enrolling
Updated: 4/28/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated:  4/30/2018
Indiana University School of Medicine
mi
from
Indianapolis, IN
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated: 4/30/2018
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated:  4/30/2018
Massachusetts General Hospital
mi
from
Boston, MA
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated: 4/30/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated:  4/30/2018
Univ of Washington
mi
from
Seattle, WA
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated: 4/30/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated:  4/30/2018
University of Alberta
mi
from
Edmonton,
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)
Status: Enrolling
Updated: 4/30/2018
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital Boston
mi
from
Boston, MA
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital of New York, Columbia Presbyterian Medical Center
mi
from
New York, NY
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital of New York, Columbia Presbyterian Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Stollery Children's Hospital
mi
from
Edmonton,
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Stollery Children's Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital Boston
mi
from
Boston, MA
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital of New York, Columbia Presbyterian Medical Center
mi
from
New York, NY
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital of New York, Columbia Presbyterian Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Children's Hospital of Pittsburgh of UMPC
mi
from
Pittsburgh, PA
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Children's Hospital of Pittsburgh of UMPC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Le Bonheur Children's Hospital
mi
from
Memphis, TN
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Le Bonheur Children's Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated:  4/30/2018
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
Cardiac Biomarkers in Pediatric Cardiomyopathy
Status: Enrolling
Updated: 4/30/2018
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials